Pegylated Recombinant Consensus Interferon Variant (Chongqing Fujin Biological Medicine)
聚乙二醇化重组集成干扰素变异体（重庆富进生物医药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NamePegylated Recombinant Consensus Interferon Variant (Chongqing Fujin Biological Medicine)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChongqing Fujin Biological Medicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChongqing Fujin Biological Medicine Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A